{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T10:21:48Z","timestamp":1773224508505,"version":"3.50.1"},"reference-count":155,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.gene.2025.149827","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:59:27Z","timestamp":1760543967000},"page":"149827","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Small noncoding RNAs: Pioneering a new therapeutic era in Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"972","author":[{"given":"Sonali","family":"Sahoo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swagata","family":"Pattanaik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Durga Madhab","family":"Kar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3401-6126","authenticated-orcid":false,"given":"Shakti Ketan","family":"Prusty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pratap Kumar","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gene.2025.149827_b0005","article-title":"Alzheimer's disease: current concept and a new hope with siRNA-liposomal system","volume":"106409","author":"Abla","year":"2024","journal-title":"J. Drug Delivery Sci. Technol."},{"issue":"37","key":"10.1016\/j.gene.2025.149827_b0010","doi-asserted-by":"crossref","first-page":"14645","DOI":"10.1523\/JNEUROSCI.1327-13.2013","article-title":"MiR-26b, upregulated in Alzheimer's disease, activates cell cycle entry, tau-phosphorylation, and apoptosis in postmitotic neurons","volume":"33","author":"Absalon","year":"2013","journal-title":"J. Neurosci."},{"issue":"19","key":"10.1016\/j.gene.2025.149827_b0015","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2174\/0115680266293212240405042540","article-title":"Noncoding RNAs in Alzheimer's disease: overview of functional and therapeutic significance","volume":"24","author":"Adiga","year":"2024","journal-title":"Curr. Top. Med. Chem."},{"issue":"1","key":"10.1016\/j.gene.2025.149827_b0020","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/s12951-023-02147-z","article-title":"Engineering siRNA therapeutics: challenges and strategies","volume":"21","author":"Ali Zaidi","year":"2023","journal-title":"J. Nanobiotechnol."},{"issue":"11","key":"10.1016\/j.gene.2025.149827_b0025","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.2174\/1570159X19666210402104054","article-title":"siRNA therapeutics: future promise for neurodegenerative diseases","volume":"19","author":"Amiri","year":"2021","journal-title":"Curr. Neuropharmacol."},{"issue":"4","key":"10.1016\/j.gene.2025.149827_b0030","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/s41386-019-0579-1","article-title":"Exosomal secretion of a psychosis-altered miRNA that regulates glutamate receptor expression is affected by antipsychotics","volume":"45","author":"Amoah","year":"2020","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.gene.2025.149827_b0035","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/nyas.14051","article-title":"Small molecule targeting of RNA structures in neurological disorders","volume":"1471","author":"Angelbello","year":"2020","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.gene.2025.149827_b0040","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/B978-0-443-23826-0.00007-6","article-title":"Gene therapies for neurodegenerative disease: current knowledge and challenges","author":"Arora","year":"2025","journal-title":"Genome Editing for Neurodegener. Dis."},{"issue":"10","key":"10.1016\/j.gene.2025.149827_b0045","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.1007\/s12035-022-02950-z","article-title":"Dysregulated miRNAs in progression and pathogenesis of Alzheimer\u2019s disease","volume":"59","author":"Arora","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.gene.2025.149827_b0050","article-title":"A review of the advances, insights, and prospects of gene therapy for Alzheimer\u2019s disease: a novel target for therapeutic medicine","volume":"148368","author":"Ataei","year":"2024","journal-title":"Gene"},{"issue":"3","key":"10.1016\/j.gene.2025.149827_b0055","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0165-0173(97)00045-3","article-title":"Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death","volume":"25","author":"Bains","year":"1997","journal-title":"Brain Res. Rev."},{"issue":"2","key":"10.1016\/j.gene.2025.149827_b0060","first-page":"101","article-title":"Key genetic similarities and differences between Alzheimer\u2019s disease and Parkinson disease","volume":"5","author":"Balmus","year":"2016","journal-title":"Acad. Romanian Sci., Ann. Series Biol. Sci."},{"issue":"3","key":"10.1016\/j.gene.2025.149827_b0065","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0022-3565(24)29640-3","article-title":"Delivery across the blood-brain barrier of antisense directed against amyloid \u03b2: reversal of learning and memory deficits in mice overexpressing amyloid precursor protein","volume":"297","author":"Banks","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.gene.2025.149827_b0070","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.bcp.2021.114469","article-title":"Non-coding RNAs: emerging from the discovery to therapeutic applications","volume":"189","author":"Baptista","year":"2021","journal-title":"Biochem. Pharmacol."},{"issue":"16","key":"10.1016\/j.gene.2025.149827_b0075","doi-asserted-by":"crossref","first-page":"8875","DOI":"10.3390\/ijms23168875","article-title":"Transcript-targeted therapy based on RNA interference and antisense oligonucleotides: current applications and novel molecular targets","volume":"23","author":"Barresi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.gene.2025.149827_b0080","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nsmb0705-569","article-title":"MicroRNAs directing siRNA biogenesis","volume":"12","author":"Bartel","year":"2005","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"1","key":"10.1016\/j.gene.2025.149827_b0085","article-title":"Advancements and challenges in antiamyloid therapy for Alzheimer\u2019s disease: a comprehensive review","volume":"2024","author":"Beshir","year":"2024","journal-title":"Int. J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.gene.2025.149827_b0090","article-title":"Neurogenomics of Alzheimer's disease (AD): an asian population review","volume":"546","author":"Besin","year":"2023","journal-title":"ClinicaChimicaActa"},{"key":"10.1016\/j.gene.2025.149827_b0095","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jare.2021.07.001","article-title":"CRISPR\/Cas9 gene editing: new hope for Alzheimer's disease therapeutics","volume":"40","author":"Bhardwaj","year":"2022","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.gene.2025.149827_b0100","doi-asserted-by":"crossref","unstructured":"Blewett, N.H., Iben, J.R., Gaidamakov, S., Maraia, R.J., 2017. La deletion from mouse brain alters pre-tRNA metabolism and accumulation of pre-5.8 S rRNA, with neuron death and reactive astrocytosis. Mol. Cell. Biol. 37(10):e00588-16.","DOI":"10.1128\/MCB.00588-16"},{"issue":"5","key":"10.1016\/j.gene.2025.149827_b0105","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1002\/alz.13784","article-title":"The six brain\u2010specific TAU isoforms and their role in ADand related neurodegenerative dementia syndromes","volume":"20","author":"Buchholz","year":"2024","journal-title":"Alzheimers Dement."},{"issue":"6257","key":"10.1016\/j.gene.2025.149827_b0110","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/343461a0","article-title":"Inhibition of neurite polarity by tau antisense oligonucleotides in primary cerebellar neurons","volume":"343","author":"Caceres","year":"1990","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.gene.2025.149827_b0115","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/biof.159","article-title":"Mitochondria, calcium, and endoplasmic reticulum stress in Parkinson's disease","volume":"37","author":"Cal\u00ec","year":"2011","journal-title":"Biofactors"},{"issue":"2","key":"10.1016\/j.gene.2025.149827_b0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115369","article-title":"Pathway-based analysis of genome-wide siRNA screens reveals the regulatory landscape of APP processing","volume":"10","author":"Camargo","year":"2015","journal-title":"PLoS One"},{"issue":"18","key":"10.1016\/j.gene.2025.149827_b0125","doi-asserted-by":"crossref","first-page":"11158","DOI":"10.1093\/nar\/gkae776","article-title":"RTP801 interacts with the tRNA ligase complex and dysregulates its RNA ligase activity in Alzheimer\u2019s disease","volume":"52","author":"Campoy-Campos","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.gene.2025.149827_b0130","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2024.1421675","article-title":"Non-coding RNAs involved in the molecular pathology of Alzheimer\u2019s disease: a systematic review","volume":"18","author":"Canoy","year":"2024","journal-title":"Front. Neurosci."},{"issue":"2","key":"10.1016\/j.gene.2025.149827_b0135","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2174\/1567205013666151218132725","article-title":"Glutamate and mitochondria: two prominent players in the oxidative stress-induced neurodegeneration","volume":"13","author":"Cassano","year":"2016","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.gene.2025.149827_b0140","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3389\/fnagi.2019.00311","article-title":"Dysfunctional mitochondria and mitophagy as drivers of Alzheimer\u2019s disease pathogenesis","volume":"11","author":"Chakravorty","year":"2019","journal-title":"Front. Aging Neurosci."},{"issue":"2","key":"10.1016\/j.gene.2025.149827_b0145","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/jnnp-2020-324283","article-title":"The future of neuroprotection in stroke","volume":"92","author":"Chamorro","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"21","key":"10.1016\/j.gene.2025.149827_b0150","doi-asserted-by":"crossref","first-page":"11870","DOI":"10.3390\/ijms222111870","article-title":"RNA modifications and RNA metabolism in neurological disease pathogenesis","volume":"22","author":"Chatterjee","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.gene.2025.149827_b0155","doi-asserted-by":"crossref","unstructured":"Chavali, P.L., Ramachandran, R., Chavali, S., 2020. Functional categories of RNA regulation. InRna-Based Regulation in Human Health and Disease. (pp. 59-83). Academic Press.","DOI":"10.1016\/B978-0-12-817193-6.00003-0"},{"issue":"10","key":"10.1016\/j.gene.2025.149827_b0160","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.tibs.2021.05.001","article-title":"Origins and evolving functionalities of tRNA-derived small RNAs","volume":"46","author":"Chen","year":"2021","journal-title":"Trends Biochem. Sci"},{"issue":"8","key":"10.1016\/j.gene.2025.149827_b0165","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.apsb.2020.01.015","article-title":"Gene therapy for neurodegenerative disorders: advances, insights and prospects","volume":"10","author":"Chen","year":"2020","journal-title":"Acta Pharm. Sinica B"},{"issue":"6","key":"10.1016\/j.gene.2025.149827_b0170","first-page":"70","article-title":"Regulation of endogenous neural stem\/progenitor cells for neural repair\u2014factors that promote neurogenesis and gliogenesis in the normal and damaged brain","volume":"18","author":"Christie","year":"2013","journal-title":"Front. Cell. Neurosci."},{"issue":"2","key":"10.1016\/j.gene.2025.149827_b0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031039","article-title":"Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer's disease families","volume":"7","author":"Cruchaga","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.gene.2025.149827_b0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089019","article-title":"A functional polymorphism in the promoter region of microRNA-146a is associated with the risk of Alzheimer disease and the rate of cognitive decline in patients","volume":"9","author":"Cui","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.gene.2025.149827_b0185","article-title":"MicroRNAs and synapse turnover in Alzheimer\u2019s disease","volume":"102377","author":"Dalal","year":"2024","journal-title":"Ageing Res. Rev."},{"issue":"2","key":"10.1016\/j.gene.2025.149827_b0190","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3390\/biomedicines13020279","article-title":"Beyond amyloid and tau: the critical role of microglia in Alzheimer\u2019s disease therapeutics","volume":"13","author":"Dias","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.gene.2025.149827_b0195","doi-asserted-by":"crossref","unstructured":"Dom\u00e9nech, E., Reina, M., Rica, G.M., Gonz\u00e1lez, C,, MT MM, AM GR, de Andr\u00e9s, \u00c1., JJ TO. Referral criteria to clinical genetics from primary care: Consensus document. Atencion Primaria. 2022;54(12):102501-.","DOI":"10.1016\/j.aprim.2022.102501"},{"key":"10.1016\/j.gene.2025.149827_b0200","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1007\/s11064-014-1481-1","article-title":"Glutathione-dependent detoxification processes in astrocytes","volume":"40","author":"Dringen","year":"2015","journal-title":"Neurochem. Res."},{"issue":"1","key":"10.1016\/j.gene.2025.149827_b0205","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s13195-023-01338-y","article-title":"CSF biomarker analysis of ABCA7 mutation carriers suggests altered APP processing and reduced inflammatory response","volume":"15","author":"Duchateau","year":"2023","journal-title":"Alzheimers Res. Ther."},{"issue":"12","key":"10.1016\/j.gene.2025.149827_b0210","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jamaneurol.2023.3861","article-title":"Exploratory tau biomarker results from a multiple ascending-dose study of BIIB080 in Alzheimer disease: a randomized clinical trial","volume":"80","author":"Edwards","year":"2023","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.gene.2025.149827_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2024.155093","article-title":"miRNAs as modulators of neuroinflammation and excitotoxicity: Implications for stroke therapeutics","author":"Elballal","year":"2024","journal-title":"Pathology-Research and Practice"},{"issue":"1","key":"10.1016\/j.gene.2025.149827_b0220","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s13195-020-00712-4","article-title":"APOE4 is associated with cognitive and pathological heterogeneity in patients with Alzheimer\u2019s disease: a systematic review","volume":"12","author":"Emrani","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.gene.2025.149827_b0225","first-page":"1","article-title":"Regulation of microRNAs","author":"Ergin","year":"2022","journal-title":"miRNomics: MicroRNA Biology and Computational Analysis"},{"key":"10.1016\/j.gene.2025.149827_b0230","first-page":"187","article-title":"Evaluation of CD33 as a genetic risk factor for Alzheimer\u2019s disease","volume":"138","author":"Estus","year":"2019","journal-title":"Actaneuropathologica"},{"key":"10.1016\/j.gene.2025.149827_b0235","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3389\/fnmol.2020.00090","article-title":"MicroRNA-146a is a wide-reaching neuroinflammatory regulator and potential treatment target in neurological diseases","volume":"13","author":"Fan","year":"2020","journal-title":"Front. Mol. Neurosci."},{"issue":"17","key":"10.1016\/j.gene.2025.149827_b0240","doi-asserted-by":"crossref","first-page":"8609","DOI":"10.3390\/ijms26178609","article-title":"Endogenous ethanol metabolism and development of MASLD-MASH","volume":"26","author":"Farr\u00e0s Sol\u00e9","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.gene.2025.149827_b0245","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejphar.2008.01.050","article-title":"Brain insulin, energy and glucose homeostasis; genes, environment and metabolic pathologies","volume":"585","author":"Gerozissis","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.gene.2025.149827_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103691","article-title":"Antisense oligonucleotides for Alzheimer's disease therapy: from the mRNA to miRNA paradigm","volume":"74","author":"Grabowska-Pyrzewicz","year":"2021","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.gene.2025.149827_b0255","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13024-018-0298-9","article-title":"New insights into the role of TREM2 in Alzheimer\u2019s disease","volume":"13","author":"Gratuze","year":"2018","journal-title":"Mol. Neurodegener."},{"issue":"17","key":"10.1016\/j.gene.2025.149827_b0260","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1093\/hmg\/ddaa179","article-title":"Gene therapy for Alzheimer\u2019s disease targeting CD33 reduces amyloid beta accumulation and neuroinflammation","volume":"29","author":"Griciuc","year":"2020","journal-title":"Hum. Mol. Genet."},{"issue":"6","key":"10.1016\/j.gene.2025.149827_b0265","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00702-021-02337-9","article-title":"Network-based analysis on genetic variants reveals the immunological mechanism underlying Alzheimer\u2019s disease","volume":"128","author":"Guo","year":"2021","journal-title":"J. Neural Transm."},{"issue":"5","key":"10.1016\/j.gene.2025.149827_b0270","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.cell.2018.03.008","article-title":"Pseudouridylation of tRNA-derived fragments steers translational control in stem cells","volume":"173","author":"Guzzi","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.gene.2025.149827_b0280","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.2147\/JIR.S422114","article-title":"Non-coding RNA in microglia activation and neuroinflammation in Alzheimer\u2019s disease","author":"He","year":"2023","journal-title":"J. Inflamm. Res."},{"issue":"8","key":"10.1016\/j.gene.2025.149827_b0285","doi-asserted-by":"crossref","first-page":"5826","DOI":"10.1007\/s12035-023-03908-5","article-title":"Alterations of mRNAs and non-coding RNAs associated with neuroinflammation in Alzheimer\u2019s disease","volume":"61","author":"Hern\u00e1ndez-Contreras","year":"2024","journal-title":"Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.gene.2025.149827_b0290","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1134\/S1068162014030169","article-title":"piRNA biogenesis and its functions","volume":"40","author":"Huang","year":"2014","journal-title":"Russ. J. Bioorg. Chem."},{"issue":"2","key":"10.1016\/j.gene.2025.149827_b0295","doi-asserted-by":"crossref","first-page":"e1463","DOI":"10.1002\/wrna.1463","article-title":"Noncoding RNAs in Alzheimer's disease","volume":"9","author":"Idda","year":"2018","journal-title":"Wiley Interdiscip. Rev.: RNA"},{"issue":"14","key":"10.1016\/j.gene.2025.149827_b0300","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.3390\/ijms21144977","article-title":"Modulation of microRNAs as a potential molecular mechanism involved in the beneficial actions of physical exercise in Alzheimer disease","volume":"21","author":"Improta-Caria","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.gene.2025.149827_b0305","article-title":"Unlocking therapeutic potential of siRNA-based drug delivery system for treatment of Alzheimer's disease","volume":"106413","author":"Jain","year":"2024","journal-title":"J. Drug Delivery Sci. Technol."},{"issue":"1","key":"10.1016\/j.gene.2025.149827_b0310","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13073-023-01155-w","article-title":"The neuroimmune axis of Alzheimer\u2019s disease","volume":"15","author":"Jorfi","year":"2023","journal-title":"Genome Med."},{"key":"10.1016\/j.gene.2025.149827_b0315","unstructured":"J\u00f6rg, M., 2022. The role of ANG and tRNA-derived fragments in aging, neurodegeneration and the pathophysiology of Alzheimer\u2019s Disease(Doctoral dissertation, Dissertation, Mainz, Johannes Gutenberg-Universit\u00e4t Mainz, 2022)."},{"issue":"11","key":"10.1016\/j.gene.2025.149827_b0320","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.3390\/antiox11112167","article-title":"The link between oxidative stress, mitochondrial dysfunction and neuroinflammation in the pathophysiology of Alzheimer\u2019s disease: therapeutic implications and future perspectives","volume":"11","author":"Jurc\u0103u","year":"2022","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.gene.2025.149827_b0325","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12929-023-00981-9","article-title":"Small interfering RNA (siRNA)-based therapeutic applications against viruses: principles, potential, and challenges","volume":"30","author":"Kang","year":"2023","journal-title":"J. Biomed. Sci."},{"issue":"2","key":"10.1016\/j.gene.2025.149827_b0330","doi-asserted-by":"crossref","first-page":"462","DOI":"10.3390\/cancers5020462","article-title":"Regulatory roles for long ncRNA and mRNA","volume":"5","author":"Karapetyan","year":"2013","journal-title":"Cancers"},{"issue":"9","key":"10.1016\/j.gene.2025.149827_b0335","first-page":"689","article-title":"Oxidative stress: major threat in traumatic brain injury","volume":"17","author":"Khatri","year":"2018","journal-title":"CNS & Neurological Disorders-Drug Targets (formerly Current Drug Targets-CNS & Neurological Disorders)"},{"key":"10.1016\/j.gene.2025.149827_b0340","article-title":"MicroRNAs in the pathophysiology of Alzheimer\u2019s disease and Parkinson's disease: an overview","volume":"1\u20135","author":"Khezri","year":"2022","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.gene.2025.149827_b0345","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.bbagrm.2015.08.007","article-title":"RISC assembly: Coordination between small RNAs and Argonaute proteins","volume":"1859","author":"Kobayashi","year":"2016","journal-title":"Biochim. Biophys. Acta (BBA)-Gene Regulatory Mech."},{"key":"10.1016\/j.gene.2025.149827_b0350","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-0716-3311-3_1","article-title":"Recent progress in the treatment strategies for Alzheimer\u2019s disease","author":"Kumar","year":"2023","journal-title":"Computational Modeling of Drugs against Alzheimer\u2019s Disease"},{"issue":"1","key":"10.1016\/j.gene.2025.149827_b0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.52547\/nl.2.1.1","article-title":"Review current and emerging treatment options for Alzheimer's disease","volume":"2","author":"Kumar Vats","year":"2023","journal-title":"Neurol. Lett."},{"issue":"7","key":"10.1016\/j.gene.2025.149827_b0360","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/s12276-023-01038-5","article-title":"Emerging roles of tRNA-derived small RNAs in cancer biology","volume":"55","author":"Lee","year":"2023","journal-title":"Exp. Mol. Med."},{"issue":"2","key":"10.1016\/j.gene.2025.149827_b0365","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.pharmthera.2005.03.004","article-title":"RNA interference: from gene silencing to gene-specific therapeutics","volume":"107","author":"Leung","year":"2005","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.gene.2025.149827_b0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yexcr.2017.10.010","article-title":"Translation of noncoding RNAs: Focus on lncRNAs, pri-miRNAs, and circRNAs","volume":"361","author":"Li","year":"2017","journal-title":"Exp. Cell Res."},{"issue":"1","key":"10.1016\/j.gene.2025.149827_b0375","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10565-022-09761-x","article-title":"The role of microRNAs in neurodegenerative diseases: a review","volume":"39","author":"Li","year":"2023","journal-title":"Cell Biol. Toxicol."},{"issue":"12","key":"10.1016\/j.gene.2025.149827_b0380","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70177","article-title":"ts RNA s: a prospective, effective therapeutic intervention for neurodegenerative diseases","volume":"30","author":"Li","year":"2024","journal-title":"CNS Neurosci. Ther."},{"issue":"10","key":"10.1016\/j.gene.2025.149827_b0385","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.3390\/biom14101340","article-title":"tRNA and tsRNA: from heterogeneity to multifaceted regulators","volume":"14","author":"Li","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.gene.2025.149827_b0390","doi-asserted-by":"crossref","DOI":"10.1042\/EBC20253022","article-title":"Epigenetic impact of endocrine-disrupting chemicals on atherosclerosis","author":"Lin","year":"2025","journal-title":"Essays Biochem."},{"issue":"4","key":"10.1016\/j.gene.2025.149827_b0395","first-page":"1748","article-title":"Dysregulation of ion channels and transporters and blood-brain barrier dysfunction in Alzheimer\u2019s disease and vascular dementia","volume":"15","author":"Liu","year":"2024","journal-title":"Aging Dis."},{"issue":"33","key":"10.1016\/j.gene.2025.149827_b0400","first-page":"3095","article-title":"Targeting \u03b2-secretase with RNAi in neural stem cells for Alzheimer's disease therapy","volume":"8","author":"Liu","year":"2013","journal-title":"Neural Regen. Res."},{"issue":"3","key":"10.1016\/j.gene.2025.149827_b0405","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41380-018-0266-3","article-title":"Novel upregulation of amyloid-\u03b2 precursor protein (APP) by microRNA-346 via targeting of APP mRNA 5\u2032-untranslated region: Implications in Alzheimer\u2019s disease","volume":"24","author":"Long","year":"2019","journal-title":"Mol. Psychiatry"},{"issue":"26","key":"10.1016\/j.gene.2025.149827_b0410","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202201740","article-title":"Delivering the promise of gene therapy with nanomedicines in treating central nervous system diseases","volume":"9","author":"Luo","year":"2022","journal-title":"Adv. Sci."},{"issue":"7","key":"10.1016\/j.gene.2025.149827_b0415","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3390\/brainsci14070633","article-title":"tRNA modifications and dysregulation: implications for brain diseases","volume":"14","author":"Lv","year":"2024","journal-title":"Brain Sci."},{"issue":"3","key":"10.1016\/j.gene.2025.149827_b0420","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.molcel.2007.07.015","article-title":"The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing","volume":"27","author":"Makeyev","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/j.gene.2025.149827_b0425","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-015-0048-1","article-title":"Genetics ignite focus on microglial inflammation in Alzheimer\u2019s disease","volume":"10","author":"Malik","year":"2015","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.gene.2025.149827_b0430","doi-asserted-by":"crossref","unstructured":"Martinez, T., Wright, N., Paneda, C., Jimenez, A.I., Lopez-Fraga, M., 2011. RNA interference-based therapeutics: harnessing the powers of nature. Drug development\u2013a case study based insight into modern strategies 265.","DOI":"10.5772\/29576"},{"issue":"2","key":"10.1016\/j.gene.2025.149827_b0435","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s12035-022-03078-w","article-title":"Role of tRNA-derived fragments in neurological disorders: a review","volume":"60","author":"Mathew","year":"2023","journal-title":"Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.gene.2025.149827_b0440","doi-asserted-by":"crossref","first-page":"796","DOI":"10.3390\/cancers12040796","article-title":"Risk of Alzheimer\u2019s disease in cancer patients: Analysis of mortality data from the US SEER population-based registries","volume":"12","author":"Mezencev","year":"2020","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.gene.2025.149827_b0445","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.drudis.2022.01.003","article-title":"Role of siRNA-based nanocarriers for the treatment of neurodegenerative diseases","volume":"27","author":"Mishra","year":"2022","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/j.gene.2025.149827_b0450","article-title":"Knockdown of BACE1\u2010AS nonprotein\u2010coding transcript modulates beta\u2010amyloid\u2010related hippocampal neurogenesis","volume":"2011","author":"Modarresi","year":"2011","journal-title":"Int. J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.gene.2025.149827_b0455","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.977411","article-title":"Clinical relevance of biomarkers, new therapeutic approaches, and role of post-translational modifications in the pathogenesis of Alzheimer\u2019s disease","volume":"14","author":"Mumtaz","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.gene.2025.149827_b0460","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3389\/fnins.2020.00494","article-title":"Nanotechnology: a promising approach for delivery of neuroprotective drugs","volume":"14","author":"Naqvi","year":"2020","journal-title":"Front. Neurosci."},{"issue":"12","key":"10.1016\/j.gene.2025.149827_b0465","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.3390\/genes12122005","article-title":"Small molecule drugs targeting non-coding RNAs as treatments for Alzheimer\u2019s disease and related dementias","volume":"12","author":"Nguyen","year":"2021","journal-title":"Genes"},{"issue":"2","key":"10.1016\/j.gene.2025.149827_b0470","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the global burden of disease study 2019","volume":"7","author":"Nichols","year":"2022","journal-title":"Lancet Public Health"},{"issue":"1","key":"10.1016\/j.gene.2025.149827_b0475","article-title":"RNA and oxidative stress in Alzheimer\u2019s disease: focus on microRNAs","volume":"2020","author":"Nunomura","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"15","key":"10.1016\/j.gene.2025.149827_b0480","doi-asserted-by":"crossref","first-page":"12498","DOI":"10.3390\/ijms241512498","article-title":"Roles of non-coding RNA in Alzheimer\u2019s disease pathophysiology","volume":"24","author":"Olufunmilayo","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2\u20133","key":"10.1016\/j.gene.2025.149827_b0485","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/03602530701468516","article-title":"Reactive oxygen species in mitochondria-mediated cell death","volume":"39","author":"Orrenius","year":"2007","journal-title":"Drug Metab. Rev."},{"issue":"6","key":"10.1016\/j.gene.2025.149827_b0490","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3390\/genes15060653","article-title":"PIWI-Interacting RNAs: a pivotal regulator in neurological development and disease","volume":"15","author":"Pan","year":"2024","journal-title":"Genes"},{"issue":"19","key":"10.1016\/j.gene.2025.149827_b0495","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2319569121","article-title":"The tRNAVal half: a strong endogenous toll-like receptor 7 ligand with a 5\u2032-terminal universal sequence signature","volume":"121","author":"Pawar","year":"2024","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.gene.2025.149827_b0500","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3892\/ijmm.2022.5208","article-title":"Role of non-coding RNAs as biomarkers and the application of omics technologies in Alzheimer's disease","volume":"51","author":"Pierouli","year":"2022","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.gene.2025.149827_b0505","doi-asserted-by":"crossref","unstructured":"Pi\u00f1eyro, D., Torres, A.G., de Pouplana, L.R., 2014. Biogenesis and evolution of functional tRNAs. InFungal RNA biology, (pp. 233-267). Cham: Springer International Publishing.","DOI":"10.1007\/978-3-319-05687-6_10"},{"key":"10.1016\/j.gene.2025.149827_b0510","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2013.09.018","article-title":"A role for tau at the synapse in Alzheimer's disease pathogenesis","volume":"76","author":"Pooler","year":"2014","journal-title":"Neuropharmacology"},{"issue":"10","key":"10.1016\/j.gene.2025.149827_b0515","doi-asserted-by":"crossref","first-page":"5548","DOI":"10.1007\/s12035-023-03414-8","article-title":"ABCA7-associated clinical features and molecular mechanisms in Alzheimer\u2019s Disease","volume":"60","author":"Qian","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.gene.2025.149827_b0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2021.111438","article-title":"TREM2, microglia, and Alzheimer\u2019s disease","volume":"195","author":"Qin","year":"2021","journal-title":"Mech. Ageing Dev."},{"issue":"12","key":"10.1016\/j.gene.2025.149827_b0525","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.3390\/genes12121959","article-title":"Advances in genetics and epigenetic alterations in Alzheimer\u2019s disease: a notion for therapeutic treatment","volume":"12","author":"Rabaneda-Bueno","year":"2021","journal-title":"Genes"},{"issue":"5","key":"10.1016\/j.gene.2025.149827_b0530","doi-asserted-by":"crossref","first-page":"4736","DOI":"10.3390\/ijms24054736","article-title":"MicroRNAs and MAPKs: evidence of these molecular interactions in Alzheimer\u2019s disease","volume":"24","author":"Raffaele","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.gene.2025.149827_b0535","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2012.02.057","article-title":"A role for neuronal piRNAs in the epigenetic control of memory-related synaptic plasticity","volume":"149","author":"Rajasethupathy","year":"2012","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.gene.2025.149827_b0540","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s10571-022-01200-z","article-title":"Roles of the miR-155 in neuroinflammation and neurological disorders: a potent biological and therapeutic target","volume":"43","author":"Rastegar-Moghaddam","year":"2023","journal-title":"Cell. Mol. Neurobiol."},{"issue":"9","key":"10.1016\/j.gene.2025.149827_b0545","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.3390\/pharmaceutics13091397","article-title":"New RNA-based breakthroughs in Alzheimer\u2019s disease diagnosis and therapeutics","volume":"13","author":"Riscado","year":"2021","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.gene.2025.149827_b0550","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1039\/C6MB00699J","article-title":"Small RNA sequencing revealed dysregulated piRNAs in Alzheimer's disease and their probable role in pathogenesis","volume":"13","author":"Roy","year":"2017","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.gene.2025.149827_b0555","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-019-1299-4","article-title":"ApoE4: an emerging therapeutic target for Alzheimer\u2019s disease","volume":"17","author":"Safieh","year":"2019","journal-title":"BMC Med."},{"issue":"2","key":"10.1016\/j.gene.2025.149827_b0560","first-page":"54","article-title":"Concept of RNA silencing and applications of sirna in healthcare","volume":"9","author":"Saha","year":"2022","journal-title":"J. Biol. Pharm. Chem. Res."},{"key":"10.1016\/j.gene.2025.149827_b0565","article-title":"siRNA drug delivery across the blood\u2013brain barrier in Alzheimer's disease","volume":"199","author":"Sajid","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.gene.2025.149827_b0570","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/cbf.3079","article-title":"Non\u2010coding RNAs: biological functions and applications","volume":"33","author":"Santosh","year":"2015","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.gene.2025.149827_b0575","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1157818","article-title":"Role of piRNA biogenesis and its neuronal function in the development of neurodegenerative diseases","volume":"15","author":"Sato","year":"2023","journal-title":"Front. Aging Neurosci."},{"issue":"2","key":"10.1016\/j.gene.2025.149827_b0580","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.expneurol.2011.09.003","article-title":"Molecular network of microRNA targets in Alzheimer's disease brains","volume":"235","author":"Satoh","year":"2012","journal-title":"Exp. Neurol."},{"issue":"7\u20138","key":"10.1016\/j.gene.2025.149827_b0585","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1101\/gad.335679.119","article-title":"Structure and mechanism of the RNA polymerase II transcription machinery","volume":"34","author":"Schier","year":"2020","journal-title":"Genes Dev."},{"issue":"8","key":"10.1016\/j.gene.2025.149827_b0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107488","article-title":"RNA modifying enzymes shape tRNA biogenesis and function","volume":"300","author":"Schultz","year":"2024","journal-title":"J. Biol. Chem."},{"issue":"21","key":"10.1016\/j.gene.2025.149827_b0595","doi-asserted-by":"crossref","first-page":"12924","DOI":"10.3390\/ijms232112924","article-title":"Amyloid beta in aging and Alzheimer\u2019s disease","volume":"23","author":"Sehar","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.gene.2025.149827_b0605","article-title":"Deciphering the role of miRNAs in alzheimer's disease: predictive targeting and pathway modulation-a systematic review","volume":"102483","author":"Sharma","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.gene.2025.149827_b0610","article-title":"Lifestyle intervention and Alzheimer disease","volume":"71","author":"Sherzai","year":"2022","journal-title":"J. Fam. Pract."},{"issue":"4","key":"10.1016\/j.gene.2025.149827_b0615","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41556-021-00652-7","article-title":"PANDORA-seq expands the repertoire of regulatory small RNAs by overcoming RNA modifications","volume":"23","author":"Shi","year":"2021","journal-title":"Nat. Cell Biol."},{"issue":"4","key":"10.1016\/j.gene.2025.149827_b0620","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41556-022-00880-5","article-title":"Exploring the expanding universe of small RNAs","volume":"24","author":"Shi","year":"2022","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.gene.2025.149827_b0625","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.870517","article-title":"Impact of anti-amyloid-\u03b2 monoclonal antibodies on the pathology and clinical profile of Alzheimer\u2019s disease: a focus on aducanumab and lecanemab","volume":"14","author":"Shi","year":"2022","journal-title":"Front. Aging Neurosci."},{"issue":"22","key":"10.1016\/j.gene.2025.149827_b0630","doi-asserted-by":"crossref","first-page":"12311","DOI":"10.3390\/ijms252212311","article-title":"From fundamentals to innovation in Alzheimer\u2019s disease: molecular findings and revolutionary therapies","volume":"25","author":"Sighencea","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.gene.2025.149827_b0635","article-title":"Advances in gene therapy approaches targeting neuro-inflammation in neurodegenerative diseases","volume":"102321","author":"Singh","year":"2024","journal-title":"Ageing Res. Rev."},{"issue":"1","key":"10.1016\/j.gene.2025.149827_b0640","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1038\/s41467-022-29790-8","article-title":"TRMT6\/61A-dependent base methylation of tRNA-derived fragments regulates gene-silencing activity and the unfolded protein response in bladder cancer","volume":"13","author":"Su","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.gene.2025.149827_b0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105576","article-title":"The role of Alzheimer's disease risk genes in endolysosomal pathways","volume":"162","author":"Szabo","year":"2022","journal-title":"Neurobiol. Dis."},{"issue":"2","key":"10.1016\/j.gene.2025.149827_b0650","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s40120-022-00338-8","article-title":"Alzheimer\u2019s disease: epidemiology and clinical progression","volume":"11","author":"Tahami Monfared","year":"2022","journal-title":"Neurol. Ther."},{"issue":"22","key":"10.1016\/j.gene.2025.149827_b0655","doi-asserted-by":"crossref","first-page":"12284","DOI":"10.3390\/ijms252212284","article-title":"Recent advances and prospects in RNA drug development","volume":"25","author":"Tani","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.gene.2025.149827_b0660","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jalz.2012.02.001","article-title":"2012 Alzheimer's disease facts and figures Alzheimer's association\u2217","volume":"8","author":"Thies","year":"2012","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.gene.2025.149827_b0665","article-title":"A review on advances of treatment modalities for Alzheimer's disease","volume":"276","author":"Thoe","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.gene.2025.149827_b0670","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2020.590034","article-title":"Extracellular vesicles loaded miRNAs as potential modulators shared between glioblastoma, and Parkinson\u2019s and Alzheimer\u2019s diseases","volume":"14","author":"Thomas","year":"2020","journal-title":"Front. Cell. Neurosci."},{"issue":"4","key":"10.1016\/j.gene.2025.149827_b0680","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1007\/s12035-018-1237-z","article-title":"APOE and Alzheimer\u2019s disease: evidence mounts that targeting APOE4 may combat Alzheimer\u2019s pathogenesis","volume":"56","author":"Uddin","year":"2019","journal-title":"Mol. Neurobiol."},{"issue":"5","key":"10.1016\/j.gene.2025.149827_b0685","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.cell.2008.02.019","article-title":"Targeted deletion reveals essential and overlapping functions of the miR-17\u223c 92 family of miRNA clusters","volume":"132","author":"Ventura","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.gene.2025.149827_b0690","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3389\/fnins.2018.00523","article-title":"Excitatory dendritic mitochondrial calcium toxicity: implications for Parkinson\u2019s and other neurodegenerative diseases","volume":"12","author":"Verma","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.gene.2025.149827_b0695","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.conb.2015.10.004","article-title":"Microglial genes regulating neuroinflammation in the progression of Alzheimer's disease","volume":"36","author":"Villegas-Llerena","year":"2016","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.gene.2025.149827_b0700","doi-asserted-by":"crossref","unstructured":"Vishnoi, A., Rani, S., 2022. miRNA biogenesis and regulation of diseases: an updated overview. MicroRNA Profiling: Methods and Protocols, 1-2.","DOI":"10.1007\/978-1-0716-2823-2_1"},{"issue":"1","key":"10.1016\/j.gene.2025.149827_b0705","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41421-021-00265-2","article-title":"CPA-seq reveals small ncRNAs with methylated nucleosides and diverse termini","volume":"7","author":"Wang","year":"2021","journal-title":"Cell Discovery"},{"issue":"5","key":"10.1016\/j.gene.2025.149827_b0710","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1523\/JNEUROSCI.5065-07.2008","article-title":"The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of \u03b2-site amyloid precursor protein-cleaving enzyme 1","volume":"28","author":"Wang","year":"2008","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.gene.2025.149827_b0715","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13024-024-00727-7","article-title":"Variants in the MS4A cluster interact with soluble TREM2 expression on biomarkers of neuropathology","volume":"19","author":"Winfree","year":"2024","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.gene.2025.149827_b0720","article-title":"Genes related to microglia polarization and immune infiltration in Alzheimer\u2019s Disease","volume":"1\u20135","author":"Xing","year":"2024","journal-title":"Mamm. Genome"},{"key":"10.1016\/j.gene.2025.149827_b0725","article-title":"Current and future treatments in Alzheimer disease: an update","volume":"12","author":"Yiannopoulou","year":"2020","journal-title":"J. Central Nervous Syst. Dis."},{"key":"10.1016\/j.gene.2025.149827_b0730","doi-asserted-by":"crossref","DOI":"10.1016\/j.tibs.2025.01.004","article-title":"Small RNA and Toll-like receptor interactions: origins and disease mechanisms","author":"Yu","year":"2025","journal-title":"Trends Biochem. Sci"},{"key":"10.1016\/j.gene.2025.149827_b0735","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1134\/S106816202001015X","article-title":"The fundamentals of miRNA biology: structure, biogenesis, and regulatory functions","volume":"46","author":"Zaporozhchenko","year":"2020","journal-title":"Russ. J. Bioorg. Chem."},{"key":"10.1016\/j.gene.2025.149827_b0740","doi-asserted-by":"crossref","first-page":"931","DOI":"10.3389\/fneur.2018.00931","article-title":"MicroRNA-21 overexpression promotes the neuroprotective efficacy of mesenchymal stem cells for treatment of intracerebral hemorrhage","volume":"9","author":"Zhang","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.gene.2025.149827_b0745","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2021.136425","article-title":"Dispositional pessimism is related to reduced respiratory sinus arrhythmia reactivity to a psychosocial stressor","volume":"771","author":"Zhang","year":"2022","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.gene.2025.149827_b0750","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115295","article-title":"Targeting epigenetics as a promising therapeutic strategy for treatment of neurodegenerative diseases","volume":"206","author":"Zhang","year":"2022","journal-title":"Biochem. Pharmacol."},{"issue":"6","key":"10.1016\/j.gene.2025.149827_b0755","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/ijc.20334","article-title":"Treatment with siRNA and antisense oligonucleotides targeted to HIF\u20101\u03b1 induced apoptosis in human tongue squamous cell carcinomas","volume":"111","author":"Zhang","year":"2004","journal-title":"Int. J. Cancer"},{"issue":"7","key":"10.1016\/j.gene.2025.149827_b0760","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.3390\/ijms26073019","article-title":"Mitochondrial small RNA alterations associated with increased lysosome activity in an Alzheimer\u2019s Disease Mouse Model uncovered by PANDORA-seq","volume":"26","author":"Zhang","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.gene.2025.149827_b0765","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105058","article-title":"Small RNA modifications in Alzheimer's disease","volume":"145","author":"Zhang","year":"2020","journal-title":"Neurobiol. Dis."},{"issue":"5","key":"10.1016\/j.gene.2025.149827_b0770","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/s41556-018-0087-2","article-title":"Dnmt2 mediates intergenerational transmission of paternally acquired metabolic disorders through sperm small non-coding RNAs","volume":"20","author":"Zhang","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.gene.2025.149827_b0775","article-title":"The role of non-coding RNAs in Alzheimer\u2019s disease: from regulated mechanism to therapeutic targets and diagnostic biomarkers","volume":"13","author":"Zhang","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.gene.2025.149827_b0780","article-title":"Exploring the potential of tsRNA as biomarkers for diagnosis and treatment of neurogenetic disorders","volume":"1\u201322","author":"Zhao","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.gene.2025.149827_b0785","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcn.2023.103820","article-title":"microRNA-146a modulates behavioural activity, neuroinflammation, and oxidative stress in adult mice","volume":"124","author":"Zhao","year":"2023","journal-title":"Mol. Cell. Neurosci."},{"issue":"2","key":"10.1016\/j.gene.2025.149827_b0790","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/procel\/pwae026","article-title":"Alzheimer\u2019s disease: insights into pathology, molecular mechanisms, and therapy","volume":"16","author":"Zheng","year":"2025","journal-title":"Protein Cell"}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037811192500616X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037811192500616X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T13:33:18Z","timestamp":1773149598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037811192500616X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":155,"alternative-id":["S037811192500616X"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2025.149827","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Small noncoding RNAs: Pioneering a new therapeutic era in Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2025.149827","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"149827"}}